Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
|
08.01 |
Side-effects of cytotoxic drugs |
|
|
08.01 |
Drugs for cytotoxic-induced side-effects |
|
|
08.01.01 |
Alkylating drugs |
|
|
08.01.02 |
Anthracyclines and other cytotoxic antibiotics |
|
|
08.01.04 |
Vinca alkaloids and etoposide |
|
|
08.01.05 |
Other antineoplastic drugs |
|
|
08.01.05 |
Arsenic trioxide |
|
|
08.01.05 |
Brentuximab vedotin |
|
|
08.01.05 |
Dacarbazine and Temozolomide |
|
|
08.01.05 |
Hydroxycarbamide |
|
|
08.01.05 |
Platinum compounds |
|
|
08.01.05 |
Porfimer sodium and temoporfin |
|
|
08.01.05 |
Protein kinase inhibitors |
|
|
08.01.05 |
Topoisomerase I inhibitors |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
|
|